Barclays Upgrades Relx (NYSE:RELX) to Overweight

Relx (NYSE:RELX) was upgraded by equities research analysts at Barclays from an “equal weight” rating to an “overweight” rating in a report issued on Friday, Marketbeat Ratings reports.

Several other equities research analysts have also issued reports on the company. Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th.

Relx Stock Performance

RELX stock opened at $48.99 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market cap of $91.04 billion, a PE ratio of 26.34, a P/E/G ratio of 2.73 and a beta of 0.90. The business has a 50 day moving average of $48.86 and a 200-day moving average of $47.60. Relx has a 12-month low of $40.25 and a 12-month high of $51.99.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Ameriprise Financial Inc. increased its holdings in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Raymond James Financial Inc. bought a new position in Relx during the fourth quarter worth about $44,516,000. Northern Trust Corp increased its stake in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock worth $99,542,000 after purchasing an additional 745,532 shares in the last quarter. Bank of Montreal Can raised its position in shares of Relx by 290.3% in the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock valued at $40,277,000 after purchasing an additional 659,547 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after buying an additional 658,655 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.